lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell

In recent years, the repurposing of conventional and chemotherapeutic drugs is recognized as an alternative strategy for health care. The main purpose of this study is to strengthen the application of non‐oncological drug metformin on breast cancer treatment in the perspective of epigenetics. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yongye, Zhou, Ziyan, Zhang, Jin, Hao, Zhenzhen, He, Yunhao, Wu, Zihan, Song, Yiquan, Yuan, Kexun, Zheng, Shanyu, Zhao, Qi, Li, Tianye, Wang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335702/
https://www.ncbi.nlm.nih.gov/pubmed/34164906
http://dx.doi.org/10.1111/jcmm.16742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335702/
https://www.ncbi.nlm.nih.gov/pubmed/34164906
http://dx.doi.org/10.1111/jcmm.16742

Ejemplares similares